We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to MAPK9

FOS — MAPK9

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Medvedev et al., J Biol Chem 1999 : Lipopolysaccharide and ceramide mimetics showed distinct kinetics of mitogen activated protein kinase phosphorylation and AP-1 induction and activated AP-1 complexes with different subunit compositions
Kim et al., J Gen Virol 1999 : IE1-driven activation of AP-1 was increased dramatically by mitogen activated protein kinase/extracellular signal regulated kinase kinase kinase 1 ( MEKK1 )
Cho et al., Free Radic Biol Med 1999 : The MAPK activity stimulated by ROS may be involved in the activation of AP-1
Balmanno et al., Oncogene 1999 : The expression of c-Fos , Fra-1 and JunB was dependent upon the activation of MAPK since these responses were inhibited by PD098059
Nandan et al., Infect Immun 1999 : Activation of phosphotyrosine phosphatase activity attenuates mitogen activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani
Shimizu et al., Cardiovasc Res 1999 : The c-fos induction, the increased AP-1 binding activity and the acceleration of DNA synthesis were all attenuated by genistein ( 100 microM ) or MAPK kinase inhibitor ( 10 or 50 microM PD98059 )
Armelin et al., Braz J Med Biol Res 1999 (Adrenal Cortex Neoplasms...) : ACTH, itself a very weak mitogen, blocks the mitogenic response effect of FGF2 in the early and middle G1 phase, keeping both ERK-MAPK activation and c-Fos induction at maximal levels
Nunomura et al., J Immunol 2000 : In response to stimulation, a marked induction of c-Fos protein expression as well as cell proliferation is detected only in CD4+8- single positive cells but not in selected and nonselected DP cells, though mitogen activated protein kinase activities and c-fos transcripts are equally induced
Lotfi et al., Braz J Med Biol Res 2000 (Adrenal Cortex Neoplasms) : FGF2 elicits a strong mitogenic response in G0/G1 arrested Y1 adrenocortical cells, that includes a ) rapid and transient activation of extracellular signal regulated kinases-mitogen activated protein kinases ( ERK-MAPK) (2 to 10 min ), b ) transcription activation of c-fos, c-jun and c-myc genes ( 10 to 30 min ), c ) induction of c-Fos and c-Myc proteins by 1 h and cyclin D1 protein by 5 h, and d ) onset of DNA synthesis stimulation within 8 h. ACTH, itself a weak mitogen, interacts with FGF2 in a complex manner, blocking the FGF2 mitogenic response during the early and middle G1 phase, keeping ERK-MAPK activation and c-Fos and cyclin D1 induction at maximal levels, but post-transcriptionally inhibiting c-Myc expression
Lepique et al., Endocr Res 2000 : In G0/G1 cell cycle arrested mouse Y1 adrenocortical tumor cells ACTH39, a weak mitogen and strong anti-mitogenic agent, blocks FGF2 mitogenic activity at G1 phase, keeping untouched ERK-MAPK activation and c-Fos protein induction
Acquaah-Mensah et al., Toxicol Appl Pharmacol 2001 : Thus this acute ethanol induced increased AP-1 transcriptional activation requires protein synthesis and involves MEK independent increased MAPK phosphorylation, on the one hand, and decreased SAPK-1 activity on the other
Wilmer et al., Kidney Int 2001 : This current study investigated the mechanisms of HG-mediated activation of p38 MAPK in cultured human mesangial cells ( HMCs ) and the effects of p38 MAPK activation on the transcription factor activator protein-1 (AP-1)
Oh et al., J Biol Chem 2001 : This Lf-induced AP-1 DNA binding activity was reduced by a p38 MAPK inhibitor
Hirokawa et al., Dig Dis Sci 2001 : The expression of early immediate genes, MAPK activity, and activation of nuclear factor activator protein-1 (AP-1) were also examined ... Early inductions of c-myc and c-fos proteins, increased activity of MAPK , and activation of AP-1 were observed by pressure loading
Mendes et al., Nitric Oxide 2002 : Finally, the p42/44MAPK inhibitor, PD 98059, prevented IL-1 induced AP-1 activation in a concentration that did not inhibit iNOS expression
Granet et al., Cell Signal 2002 : Downregulation of protein kinase C ( PKC ) and COX1/2 or inhibition of ERK1/2, p38 ( MAPK ) or src kinases had no major effect on AP-1 mRNA expression in the Flexcell
Bhattacharyya et al., Biochem J 2002 : While ERK1/2 activation could be linked to enhanced DNA binding of activator protein-1 (AP-1), p38 MAPK signalling did not affect AP-1 DNA binding
Sanjo et al., Mol Cell Biol 2003 (Fetal Death...) : Recently, serine/threonine kinase TAK1 and TAK1 binding protein 1 and 2 (TAB1/2) have been identified as molecules involved in IL-1 induced TRAF6 mediated activation of AP-1 and NF-kappa B via mitogen activated protein ( MAP ) kinases and I kappa B kinases, respectively
Kikkawa et al., Am J Kidney Dis 2003 (Diabetic Nephropathies...) : We also found that inhibition of MAPK by PD98059, an inhibitor of MAPK, or mitogen activated extracellular regulated protein kinase kinase prevented enhancement of activated protein-1 (AP-1) DNA binding activity and fibronectin expression in cultured mesangial cells exposed to mechanical stretch in an in vivo model of glomerular hypertension
Tu et al., Cardiovasc Toxicol 2003 : Distinct roles of p42/p44 ( ERK ) and p38 MAPK in oxidant induced AP-1 activation and cardiomyocyte hypertrophy
Silvers et al., Neoplasia (New York, N.Y.) 2003 (Skin Neoplasms) : The role of JNK and p38 MAPK activities in UVA induced signaling pathways leading to AP-1 activation and c-Fos expression
Parameswaran et al., Cell Physiol Biochem 2003 : Both an AM-induced increase in AP-1 mRNA expression and AP-1 luciferase activities were inhibited by H89 ( protein kinase-A inhibitor ) and SB203580 ( p38 MAPK inhibitor )
Ma et al., J Immunol 2004 : Studies conducted to understand the regulation of AP-1 and NF-kappaB activation by JNK MAPK revealed that both DXM and SP600125 inhibited IL-12p40 gene transcription by inhibiting the activation of AP-1 and NF-kappaB transcription factors as revealed by luciferase reporter and gel mobility shift assays
Ryoo et al., Cardiovasc Res 2004 : These data demonstrated that LDL stimulates SMCs to induce IL-8 production in dose- and time dependent manners at the transcription level and that the LDL signaling in hAoSMCs is conveyed via the generation of H2O2, the phosphorylation of p38 MAPK , the activation of AP-1 , and the participation of NF-kappaB
Fradette et al., Curr Drug Metab 2004 (Anoxia...) : The up-regulation of CYP3A6 implies a PTK- and p42/44MAPK dependent stabilization/activation, nuclear translocation of HIF-1 and AP-1 , binding to CYP3A6 promoter, and transactivation of the gene to induce CYP3A6 expression
Park et al., Biochem Biophys Res Commun 2004 (MAP Kinase Signaling System) : Taken together, these results demonstrate that naturally occurring furosin has an inhibitory activity on both osteoclast differentiation and function through mechanisms involving inhibition of the RANKL induced p38MAPK and JNK/AP-1 activation as well as actin ring formation
Iles et al., Free Radic Biol Med 2005 : Downstream, MAPK activation leads to increased AP-1 binding, which mediates GCL induction
Sawai et al., Oncogene 2006 (Disease Progression...) : Overexpressed ILK enhances the IL-1alpha induced p38 MAPK phosphorylation more strongly through glycogen synthase kinase 3 ( GSK-3 ) activation, and subsequently induces AP-1 activation, which promotes aggressive capabilities of pancreatic cancer cells
Mossman et al., Am J Respir Cell Mol Biol 2006 (Lung Neoplasms...) : Work from our laboratories supports the concept that MAPK signaling and AP-1 transactivation by cigarette smoke and asbestos may synergize in lung epithelial cell injury, compensatory proliferation of lung epithelial cells, and carcinogenesis, supporting a mechanistic framework for the striking increases in lung cancer incidence in asbestos workers who smoke
Chen et al., J Biol Chem 2006 : The effects of Cybr on nuclear factor of activated T cells and AP-1 are dependent on MAPK activation, and enhanced activation of this cascade results in cooperation between the two transcription factors in the regulation of gene expression
Miyamoto et al., J Pharmacol Sci 2006 : Furthermore, activation of CaM kinase IV and MAPK increased phosphorylation of CREB ( cyclic AMP response element binding protein ) and expression of c-Fos by stimulation of gene expression
Vlotides et al., Mol Endocrinol 2006 (Pituitary Neoplasms) : EGF induced EGFR and ERK1/2 phosphorylation was followed by rapid MAPK kinase/ERK kinase dependent activation of Elk-1 and c-Fos
Gough et al., J Biol Chem 2007 (MAP Kinase Signaling System) : Thus, IFNgamma induced JAK1- and STAT1 independent activation of the ERK mitogen activated protein kinase pathway, phosphorylation of c-Jun, and activation of AP-1 DNA binding, which are important for the induction of a subset of ISGs
Hou et al., Arch Biochem Biophys 2007 : The results demonstrated that PDGG suppressed COX-2 expression via blocking MAPK mediated activation of nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1) and C/EBPdelta
Tirumurugaan et al., Am J Physiol Lung Cell Mol Physiol 2007 (MAP Kinase Signaling System) : We determined the role of mitogen activated protein kinase ( MAPK ) in the activation of NF-kappaB and AP-1 in the regulation of CD38 expression in HASM cells
Lee et al., J Mol Med (Berl) 2007 (Disease Models, Animal...) : Although C. difficile toxin A is known to induce nuclear factor-kappaB mediated chemokine expression in intestinal epithelial cells, little is known about its effect on the regulation of activator protein-1 (AP-1) by mitogen activated protein kinase ( MAPK )
Peng et al., Toxicology 2007 (Glioma) : Penta-acetyl geniposide induced apoptosis involving transcription of NGF/p75 via MAPK mediated AP-1 activation in C6 glioma cells
Lee et al., Cardiovasc Res 2007 : Down-regulation of NQO1 inhibits MMP-9 gene expression by suppressing activation of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) , well-known key elements mediating MMP-9 gene expression in its promoter, via the p38 MAPK and JNK pathways
Suzuki et al., J Cell Physiol 2008 (Hemorrhage) : Two hrs thereafter, Kupffer cells and SMPhi production of IL-6, TNF-alpha, and IL-10, activation of MAPK ( p38, ERK-1/2, and JNK ), and transcription factors ( NF-kappaB and AP-1 ) were determined
Sun et al., Biochem Biophys Res Commun 2008 : We find that TNF induced oscillations in p65 and p50 recruitment to the CD38 promoter correlated with recruitment of MAPK induced AP-1 recruitment, as analyzed by quantitative ChIP analysis
Ding et al., FEMS Immunol Med Microbiol 2008 : The goal of this study was to investigate the effects of Helicobacter pylori and mitogen activated protein kinases ( MAPK ) on AP-1 subcomponents expression and AP-1 DNA binding activity in gastric epithelial cells
Wang et al., Glia 2009 (MAP Kinase Signaling System) : Here we report that oxLDL induces expression of proMMP-9 via a MAPK dependent AP-1 activation in rat brain astrocyte ( RBA ) -1 cells
Lee et al., J Dermatol Sci 2008 : However, in the AP-1 ( activator protein-1 ) luciferase reporter assay and in the Western blot analysis for mitogen activated protein kinases ( MAPKs ), carvacrol induced the activation of the AP-1 promoter and the phosphorylation of JNK and ERK1/2 ( p42/44 MAPK ), but did not induce the phosphorylation of p38 MAPK
Han et al., Toxicol Appl Pharmacol 2008 : Phosphatidylinositol 3 (PI3)-kinase, its downstream signaling molecule, Akt, and mitogen activated protein kinases ( MAPK ) were also significantly activated by the o, p'-DDT induced AP-1 and CRE activation
Skinner et al., Neuroscience 2008 : Induction of c-Fos was significantly reduced in the presence of inhibitors of protein kinase C, mitogen activated protein kinase ( MAPK ) and phospholipase C
Dragomir et al., Thromb Haemost 2008 : The MAPK inhibitors blocked the phosphorylation of IkBalpha and c-jun, indicating the role of MAPK in NF-kappaB and AP-1 activation in SMC under HG conditions
Nold-Petry et al., Proc Natl Acad Sci U S A 2009 : Increasing evidence demonstrates that interleukin (IL)-32 is a pro-inflammatory cytokine, inducing IL-1alpha, IL-1beta, IL-6, tumor necrosis factor (TNF)-alpha, and chemokines via nuclear factor (NF)-kappaB, p38 mitogen activated protein kinase ( MAPK ), and activating protein (AP)-1 activation
Khan et al., Mol Cell Biochem 2010 (Escherichia coli Infections...) : In this article, we have shown that EAEC induced activation of mitogen activated protein kinases ( MAPK ) ( ERK-1/2, JNK and p38MAPK ) in cultured human intestinal epithelial cells ( INT-407 ) leads to the induction of DNA binding activity of NF-kappaB and AP-1 , resulting in IL-8 production
Son et al., Mol Cells 2009 (Lymphoma...) : Mitogen activated protein kinases ( MAPK ) affect the activation of activator protein-1 (AP-1) , which plays an important role in regulating a range of cellular processes
Kim et al., Neurochem Int 2010 (Parkinson Disease) : These results collectively suggest that ROS, PI3 kinase, NF-kappaB, and AP-1 are commonly involved in 6-OHDA- and MPP ( + ) -induced MMP-9 gene expression, and that p38 MAPK is differentially involved
Chen et al., Chem Biol Interact 2010 : Nitrosative stress induces osteoblast apoptosis through downregulating MAPK mediated NFkappaB/AP-1 activation and subsequent Bcl-X ( L ) expression
Yang et al., Atherosclerosis 2010 : N-acetylcysteine, SP600125 ( JNK inhibitor ) and SB203580 ( p38 MAPK inhibitor ) attenuated TNF-alpha induced DNA binding activities of both AP-1 and NF-kappaB
Wang et al., Biochem Biophys Res Commun 2010 : Mitogen activated protein kinase ( MAPK ) cascades play an important role in regulation of AP-1 activity through the phosphorylation of distinct substrates
Persichini et al., Neurosci Lett 2010 : Moreover, we have observed that IL-1ß regulates the expression of Cp and Fpn genes through ( i ) p38 MAPK mediated activation of C/EBP transcription factor, ( ii ) ERK1/2-, JNK1- and partially p38 MAPK dependent activation of AP-1 , and through ( iii ) activation of NF-?B partially mediated by p38 MAPK
Lee et al., Biochem Biophys Res Commun 2011 (Breast Neoplasms...) : DHAvD also suppressed activation of mitogen activated protein kinase ( MAPK ), and MAPK mediated nuclear factor-kappa B ( NF-?B ) and activator protein-1 (AP-1) activations in TPA treated MCF-7 cells
Ben et al., J Surg Res 2012 (Acute Lung Injury...) : Following intestinal I/R, phosporylation of p38 MAPK and activation of NF-?B and AP-1 were significantly inhibited in lung tissue from TLR4 mutant mice compared with WT controls
Lv et al., PloS one 2011 : In this study, the role of p38 MAPK in AP-1 activation and in the EMT in the human proximal tubular epithelial cell line ( HK-2 ) under high glucose concentration conditions is investigated
Butoi et al., Biochim Biophys Acta 2011 : Monocyte-SMC interaction induced the phosphorylation of p38MAPK and activation of AP-1 transcription factor
Jia et al., Int J Colorectal Dis 2012 (Colonic Neoplasms...) : Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell
Zhu et al., Cytokine 2012 : Moreover, IL-1ß initiated AP-1 activation was blocked by p38 MAPK , ERK 1/2, or JNK inhibition, whereas NF-?B activity remained unaltered by all the above pathway specific inhibitors
Coste et al., Behav Brain Res 2012 (MAP Kinase Signaling System...) : Our results indicate that PAK 5 is involved in formalin induced inflammatory nociception through regulation of MAPK induced c-Fos-activation and formalin-specific TRP-channels
Luo et al., Cell Growth Differ 1997 (Astrocytoma) : CGP 41251 and tamoxifen selectively inhibit mitogen activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells
Ito et al., Hepatology 1998 (Carcinoma, Hepatocellular...) : Furthermore, in 25 of 26 cases of HCC which genomic DNA was available, 22 cases without genomic DNA amplification exhibited positive correlation, not only between protein expression of c-Fos and cyclin D1, but also between MAPK/ERK activation and cyclin D1 expression
Kawata et al., J Biol Chem 1998 : The expression of c-Fos , a nuclear transcription factor, is induced by high pressure, and the induction is significantly inhibited by PD98059 ( 50 microM ), an upstream MAPK/extracellular signal regulated kinase kinase ( MEK ) inhibitor of MAPK
Delpedro et al., J Interferon Cytokine Res 1998 : In addition, deficient protein kinase C (PKC)-alpha, PKC-/betaI, and PKC-betaII activation, deficient mitogen activated protein kinase ( MAP-Kinase ) activation , and deficient expression of c-Fos and c-Jun was observed in LPS activated aged monocytes when compared with LPS activated young monocytes
Yi et al., J Immunol 1998 (Lymphoma, B-Cell) : CpG DNA also induces the phosphorylation of activating transcription factor-2, c-Jun, and mitogen activated protein kinase ( MAPK) activated protein kinase 2 as well as the activation of activator protein-1 (AP-1) DNA binding
Cook et al., Mol Cell Biol 1999 : In cells expressing a conditionally active form of Raf-1 ( DeltaRaf-1 : ER ), we observed that selective, sustained activation of Raf-MEK-MAPK was sufficient to induce expression of Fra-1, Fra-2, and JunB but, interestingly, induced little or no c-Fos or c-Jun